Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1231930-82-7
Purity
95%
Abemaciclib is an antitumor agent and dual inhibitor of cyclin-dependent kinases 4 and 6 that are involved in the cell cycle and promotion of cancer cell growth in case of unregulated activity. Abemaciclib is used to treat HR+ HER2- advanced or metastatic breast cancer.
Properties
Name
Abemaciclib mesylate
Smiles
CCN1CCN(CC=2C=CC(NC=3N=CC(F)=C(N3)C=4C=C(F)C=5N=C(C)N(C(C)C)C5C4)=NC2)CC1.CS(=O)(=O)O
Targets
Please log in to see this information
SDS
LY2835219 | abemaciclib | abemaciclib mesylate | abemaciclib methanesulfonate | abemaciclib monomesylate
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$53
2 mg
$54
5 mg
$55
10 mg
$66
15 mg
$73
20 mg
$81
25 mg
$90
30 mg
$100
35 mg
$108
40 mg
$116
45 mg
$122
50 mg
$136
75 mg
$208
100 mg
$238
Quantity
1
Total amount
$ 55
LY2835219 | abemaciclib | abemaciclib mesylate | abemaciclib methanesulfonate | abemaciclib monomesylate
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.